Aptevo Therapeutics Inc. (APVO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-26) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-11) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | 8-K (2025-04-28) | ||
| 10-K | FY-2024 | 8-K (2025-02-14) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-08) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-05) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-10) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Cash Flows | ||
| Condensed Consolidated Statements of Changes In Stockholders' Deficit Equity (unaudited) | — |
|
| Condensed Consolidated Statements of Changes In Stockholders' Equity (deficit) | — |
|
| Consolidated Statement of Changes In Stockholders' Equity | ||
| Condensed Consolidated Statements of Changes In Stockholders' Deficit Equity (unaudited) (P) | — |
|
| Consolidated Statement of Changes In Stockholders' Equity (P) | ||
| Notes | ||
| 401(k) Savings Plan | — |
|
| Cash and Cash Equivalents | ||
| Collaboration Agreements | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Debt | ||
| Discontinued Operations | ||
| Equity | ||
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Leases and Contingencies | — |
|
| Liability Related To Sale of Royalties | ||
| Nature of Business and Significant Accounting Policies | ||
| Net Income (loss) Per Share | ||
| Net Loss Per Share | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities | ||
| Property and Equipment, Net | — |
|
| Reverse Stock Split | ||
| Segment Information | ||
| Subsequent Events | ||
| Xoma Transaction | ||